Altoida

Detecting an MCI and Amyloid Digital Neuro Signature (DNS) using Altoida’s multimodal digital biomarkers. Ground Truth data collection.

To be eligible for this study, a potential participant must:

• Male or female, 50+ years at the time of consent.
• At least four years of formal education (from primary school onwards).
• Adequate vision to complete the Altoida assessment and neuropsychological tests with or without corrective lenses.
• Has Not been in a clinical trial longer than six months of any potential disease-modifying anti-amyloid AD treatment.